pyrazinamide has been researched along with Hematologic Diseases in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VERWILGHEN, R | 1 |
| REYBROUCK, G | 1 |
| CALLENS, L | 1 |
| COSEMANS, J | 1 |
| Bozóky, G | 1 |
| Ruby, E | 1 |
| Góhér, I | 1 |
| Tóth, J | 1 |
| Mohos, A | 1 |
2 other studies available for pyrazinamide and Hematologic Diseases
| Article | Year |
|---|---|
ANTITUBERCULOUS DRUGS AND SIDEROBLASTIC ANAEMIA.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hypochromic; Anemia, Siderobl | 1965 |
[Hematologic abnormalities in pulmonary tuberculosiss].
Topics: Anemia; Antitubercular Agents; Ethambutol; Hematologic Diseases; Humans; Leukopenia; Pancytopenia; P | 1997 |